Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for centrally mediated abdominal pain syndrome
ChiCTR1900028026Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pregabalin in functional abdominal pain syndrome (CAPS) (3 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Abdominal pain score. Started Jan 2020; status: recruiting.
02
Drugs
pregabalin
03
Conditions
functional abdominal pain syndrome (CAPS)
Beyond the preview
Go deeper on ChiCTR1900028026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028026.